MoneyWorks4Me

The Sales for the quarter ended June 2024 of Rs. 81.57 millions rose by 46.16% from Rs. 55.81 millions.Net profit for the quarter ended June 2024 increased significantly by 56.72% to Rs. 4.20 millions from Rs. 2.68 millions.Operating profit for the quarter ended June 2024 rose to 9.03 millions as compared to 5.04 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 81.57 55.81 46.16 81.57 55.81 46.16 272.97 197.67 38.09
Other Income 0.12 0.05 140.00 0.12 0.05 140.00 0.06 0.34 -82.35
PBIDT 9.03 5.04 79.17 9.03 5.04 79.17 44.65 35.87 24.48
Interest 0.79 0.41 92.68 0.79 0.41 92.68 1.94 2.35 -17.45
PBDT 8.24 4.63 77.97 8.24 4.63 77.97 42.21 33.52 25.92
Depreciation 2.56 1.01 153.47 2.56 1.01 153.47 10.44 6.16 69.48
PBT 5.68 3.62 56.91 5.68 3.62 56.91 31.77 27.36 16.12
TAX 1.48 0.94 57.45 1.48 0.94 57.45 14.41 6.15 134.31
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 3.22 0.09 3477.78
PAT 4.20 2.68 56.72 4.20 2.68 56.72 17.36 21.21 -18.15
Equity 64.37 64.37 0.00 64.37 64.37 0.00 64.37 64.37 0.00
PBIDTM(%) 10.18 8.30 22.62 11.07 9.03 22.59 15.04 16.77 -10.33
Peers
Company Name CMP
Sun Pharma. Inds. 1846.00
Dr. Reddys Labs. 1225.20
Cipla 1390.60
Lupin 2068.90
Zydus Lifesciences 1216.70
View more..